Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of fluid...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Nephrotic Syndrome III : Nursing Management01:24

Nephrotic Syndrome III : Nursing Management

Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

RIBOFLAVIN deficiency in rheumatic Diseases: A call for clinical trials.

Rheumatology and immunology research·2026
Same author

Polyarteritis nodosa and antiphospholipid syndrome: a systematic review of a rare and challenging overlap between vasculitis and thrombotic vasculopathy.

Clinical rheumatology·2026
Same author

Intermittent hydrarthrosis (periodic synoviosis): A narrative review.

Autoimmunity reviews·2026
Same author

Antidotes in Homeopathy: Classical Doctrine, Clinical Relevance and Scientific Re-interpretation.

Homeopathy : the journal of the Faculty of Homeopathy·2026
Same author

Multiple Tophi and Tophus Aspirate in a Gouty Patient.

The Israel Medical Association journal : IMAJ·2026
Same author

Hydroxychloroquine as an Adjunct Therapy for Secondary Thrombosis Prevention in Primary Antiphospholipid Syndrome: A Systematic Review and Meta-analysis.

Rheumatology and therapy·2026

Related Experiment Video

Updated: May 26, 2026

Ferric Chloride-induced Murine Thrombosis Models
10:37

Ferric Chloride-induced Murine Thrombosis Models

Published on: September 5, 2016

Dietetic issues in antiphospholipid syndrome.

Karin Klack, Jozélio Freire de Carvalho

    Rheumatology International
    |December 24, 2011
    PubMed
    Summary

    Dietary management is crucial for antiphospholipid syndrome (APS) patients, addressing vitamin K intake, managing risk factors like obesity and hypertension, and ensuring adequate calcium for bone health. Nutritional counseling aids in improving quality of life and controlling comorbidities.

    Area of Science:

    • Nutrition Science
    • Rheumatology
    • Internal Medicine

    Background:

    • Antiphospholipid syndrome (APS) presents unique dietary challenges, particularly concerning vitamin K intake due to anticoagulant therapy.
    • Key comorbidities like obesity, dyslipidemia, hypertension, and diabetes mellitus are significant risk factors for hypercoagulability in APS patients.
    • Osteoporosis and osteopenia are prevalent concerns in APS, necessitating attention to dietary calcium intake, especially for patients on anticoagulants and heparins.

    Discussion:

    • This review highlights the critical interplay between diet and APS management, focusing on vitamin K interactions with anticoagulants.
    • It emphasizes the importance of a healthy diet to mitigate risks associated with obesity, dyslipidemia, hypertension, and diabetes mellitus, all contributing to hypercoagulability.
    • Adequate calcium intake is discussed as essential for preventing or managing osteoporosis/osteopenia in APS patients undergoing anticoagulant and heparin treatments.

    Related Experiment Videos

    Last Updated: May 26, 2026

    Ferric Chloride-induced Murine Thrombosis Models
    10:37

    Ferric Chloride-induced Murine Thrombosis Models

    Published on: September 5, 2016

    Key Insights:

    • Vitamin K intake requires careful management in APS patients on anticoagulants to maintain therapeutic efficacy and safety.
    • Addressing modifiable dietary risk factors (obesity, dyslipidemia, hypertension, diabetes) is paramount for reducing hypercoagulability.
    • Calcium-rich diets are vital for bone health in APS patients, counteracting potential side effects of anticoagulant therapies.

    Outlook:

    • Integrating comprehensive nutrition counseling with medical follow-up can empower APS patients to adopt healthier dietary habits.
    • This integrated approach aims to enhance patient quality of life and achieve better control over associated comorbidities.
    • Further research into personalized dietary interventions for APS could optimize long-term patient outcomes and disease management.